Suchergebnisse - (Subject:"4QWG6N8QKH")

PubPharm (200)

1

What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines

enthalten in: Clinical rheumatology | 2023

von Conley, B. | Bunzli, S. | Bullen, J. | +7

2

Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis : Emulating a Randomized Trial in Observational Data

enthalten in: Clinical pharmacology and therapeutics | 2022

von Barbulescu, A. | Askling, J. | Saevarsdottir, S. | +2

3

Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis : an open-label, non-inferiority randomized controlled trial

enthalten in: Rheumatology international | 2022

von Belani, P. | Kavadichanda, C. | Negi, V.

4

Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis : Results From a Swedish Randomized Controlled Trial

enthalten in: Arthritis care & research | 2021

von Olofsson, T. | Wallman, J. | Jöud, A. | +5

5

Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis

enthalten in: Arthritis care & research | 2021

von Curtis, J. | Palmer, J. | Reed, G. | +4

6

Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Källmark, H. | Einarsson, J. | Nilsson, J. | +4

CommentIn: Arthritis Rheumatol. 2021 Jul;73(7):1124-1126. - PMID 33779069

7

Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine

enthalten in: Rheumatology (Oxford, England) | 2021

von Miller, H. | Wallman, J. | Petersson, I. | +6

8

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission : The ARCTIC REWIND Randomized Clinical Trial

enthalten in: JAMA | 2021

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +18

CommentIn: JAMA. 2021 Sep 7;326(9):872-873. - PMID 34547087

9

Cardiac Dysfunction in Rheumatoid Arthritis : The Role of Inflammation

enthalten in: Cells | 2021

von Chen, J. | Norling, L. | Cooper, D.

10

The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity : the study protocol of a randomized controlled clinical Trial (ESCoRT study)

enthalten in: BMC medical informatics and decision making | 2021

von Zhao, J. | Zhou, W. | Wu, Y. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]